Trial intelligence / Profile preview

Ketone Ester in Alcohol Use Disorder

NCT04616781Phase 3Recruiting

Sponsor
University of Pennsylvania
Start
Apr 2021
Primary completion
Dec 2026
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in alcohol use disorder (AUD) (2 arms), sponsored by University of Pennsylvania. Primary endpoints: Alcohol consumption at 4 hours, Alcohol craving at 4 hours and 1 more. Started Apr 2021; status: recruiting.

02

Conditions

alcohol use disorder (AUD)

Beyond the preview

Go deeper on NCT04616781.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04616781.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call